Related Experiment Video
Updated: Sep 16, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research Physicians
David E Gerber1, Nikhil I Khushalani2, Ang Gao1
11Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
Physician faculty in cancer research face varied support and clinical demands. Evaluation increasingly focuses on clinical productivity, impacting research careers.
Area of Science:
- Oncology Research Faculty Support
- Physician Scientist Career Development
Background:
- Fewer physicians are entering research careers, necessitating adequate time and financial support for high-quality research.
- Resources for physician researchers can fluctuate over time and across institutions.
Purpose of the Study:
- To assess changes in physician faculty recruitment, effort, and evaluation between 2019 and 2021.
- To analyze the resources and clinical requirements for clinical research faculty and physician-scientists.
Main Methods:
- Surveys were distributed to NCCN Member Institutions in 2019 and 2021.
- Statistical models (linear, logistic mixed-effect, Spearman's rank correlation) were used to analyze survey data.
Main Results:
- Clinical research faculty start-up packages were less than $50,000/year at 43% of institutions and lasted ≤3 years at 81%.
- Physician-scientist faculty start-up packages were less than $50,000/year at 10% of institutions and lasted ≤3 years at 48%.
- Outpatient clinic requirements for clinical research faculty remained stable, while inpatient service requirements decreased.
Conclusions:
- Clinical research physicians represent a variable proportion of faculty across cancer centers.
- These physicians face diverse clinical demands, with evaluation increasingly tied to clinical productivity.
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Clinical Trials: Overview
Cancer Survival Analysis
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targeted Cancer Therapies
There are several types of targeted therapies against...